NTAGI recommends reducing Covishield dose gap to 8-16 weeks

The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap of Covid vaccine Covishield to 8 to 16 weeks after 1st dose of vaccine in view of ongoing Omicron pandemic, said a source on Sunday.

Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose under the national vaccination drive. India’s apex body on immunisation NTAGI has recommended this in view of recent surge in the global Covid caseload.

The recommendation is expected to ramp up the administration of the second dose of Covishield to the remaining population amid rising cases in European nations and some other countries.

The government had on May 13, 2021 extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks based on the recommendations by NTAGI that provides guidance to the Union Health Ministry on the immunisation.

Medlarge

Recent Posts

Health experts highlight informational gap in non-communicable diseases response

Recognizing the increasing burden of non-communicable diseases (NCDs) and the pivotal role of improving understanding…

12 hours ago

Finally Delhi to implement Ayushman Bharat Yojana, signs pact with Health Ministry

The BJP-led Delhi government on Saturday entered into an agreement with the Union health ministry…

1 day ago

In a first, ICMR to study zoonotic diseases that could spill over from birds to humans

In a one of its kind research, India is set to begin an inter-ministerial scientific…

2 days ago

World Homoeopathy Day 2025: Symposium to expand avenues of ‘Gentle Therapeutic System’

As an ode to Dr. Samuel Hahnemann, the founder of homoeopathy, on his birth-anniversary on…

3 days ago

RJD chief Lalu Yadav admitted at AIIMS

RJD president and former Bihar chief minister Lalu Prasad was on Wednesday taken to Delhi…

5 days ago

EVOLVE 2025 held to discuss advancements in extracellular vesicle (EV) research in AIIMS

The Indian Society for Extracellular Vesicles (InSEV) successfully hosted its inaugural conference, EVOLVE 2025, from…

5 days ago